These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6135664)

  • 1. Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.
    Cross SS; Brede G; Tucker HS; Maloney M; Montour JL; Hard RC
    Infect Immun; 1983 Aug; 41(2):570-7. PubMed ID: 6135664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitized (T6 x RFM)F1 donor B cells contribute to hypergammaglobulinemia and to poor primary responses in RFM mice with allogenic host versus graft disease.
    Hard RC; Benson LL
    Cell Immunol; 1986 Sep; 101(2):593-603. PubMed ID: 3489542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.
    Hard RC; Patel MR; Keller LM; Linna TJ
    Immunology; 1988 Mar; 63(3):457-64. PubMed ID: 3258280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.
    Hard RC
    Clin Exp Immunol; 1975 Nov; 22(2):330-40. PubMed ID: 1082403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent difference in the roles of spleen and lymph nodes in the pathogenesis of host-versus-graft disease in murine parent/F1 chimeras.
    Hard RC; Benson LL; Keller LM
    Transplantation; 1987 Sep; 44(3):434-9. PubMed ID: 3498242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.
    Hard RC; Montour JL; Fuchs BA
    Clin Exp Immunol; 1995 May; 100(2):352-8. PubMed ID: 7743676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic studies of RFM mice which are susceptible to host versus graft disease following the perinatal inoculations of (T6 x RFM)F1 spleen cells and of T6T6 mice which are not.
    Hard RC; Cross SS; Brede G; Montour JL; Carter WH
    Clin Immunol Immunopathol; 1981 Sep; 20(3):427-35. PubMed ID: 6978788
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic induction of malignant lymphoma: graft-vs-host reaction-induced B cell lymphomas contain integrations of predominantly ecotropic murine leukemia proviruses.
    Pals ST; Zijstra M; Radaszkiewicz T; Quint W; Cuypers HT; Schoenmakers HJ; Melief CJ; Berns A; Gleichmann E
    J Immunol; 1986 Jan; 136(1):331-9. PubMed ID: 2999247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted expression of ecotropic virus by thymocytes of leukemia-resistant (AKR X NZB)F1 mice.
    Datta SK; Schwartz RS
    J Exp Med; 1978 Jul; 148(1):329-34. PubMed ID: 209123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice.
    Bedigian HG; Johnson DA; Jenkins NA; Copeland NG; Evans R
    J Virol; 1984 Sep; 51(3):586-94. PubMed ID: 6088784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus.
    Chesebro B; Portis JL; Wehrly K; Nishio J
    Virology; 1983 Jul; 128(1):221-33. PubMed ID: 6308893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphomas in C3H mice perinatally inoculated with (C3H X T6) F1 or C3H spleen cells.
    Hard RC; Cross SS
    Eur J Cancer (1965); 1980 Jun; 16(6):817-31. PubMed ID: 6250852
    [No Abstract]   [Full Text] [Related]  

  • 18. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. III. Characterization of C-type viruses isolated from lymphomas induced by milk transmission of B-ecotropic virus.
    Zijlstra M; de Goede RE; Schoenmakers HJ; Schinkel AH; Hesselink WG; Portis JL; Melief CJ
    Virology; 1983 Feb; 125(1):47-63. PubMed ID: 6187128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic alteration in retroviral gene expression by leukemia-resistant thymocytes differentiating in leukemia-susceptible recipients.
    Datta SK; Waksal SD; Schwartz RS
    Cell; 1980 Jan; 19(1):171-9. PubMed ID: 6244102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas.
    Vasmel WL; Zijlstra M; Radaszkiewicz T; Leupers CJ; de Goede RE; Melief CJ
    J Virol; 1988 Sep; 62(9):3156-66. PubMed ID: 2841468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.